BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29547938)

  • 1. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
    He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
    Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opa interacting protein 5 acts as an oncogene in bladder cancer.
    He X; Hou J; Ping J; Wen D; He J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
    Li Y; Xiao F; Li W; Hu P; Xu R; Li J; Li G; Zhu C
    Oncol Rep; 2019 Apr; 41(4):2075-2088. PubMed ID: 30816485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
    Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
    Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling.
    Peng JM; Tseng RH; Shih TC; Hsieh SY
    Cancer Lett; 2021 Jan; 497():66-76. PubMed ID: 33068700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
    Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
    Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.
    Wang Y; Alla V; Goody D; Gupta SK; Spitschak A; Wolkenhauer O; Pützer BM; Engelmann D
    Nucleic Acids Res; 2016 Jan; 44(1):117-33. PubMed ID: 26350215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis.
    Xu TP; Wang YF; Xiong WL; Ma P; Wang WY; Chen WM; Huang MD; Xia R; Wang R; Zhang EB; Liu YW; De W; Shu YQ
    Cell Death Dis; 2017 Jun; 8(6):e2837. PubMed ID: 28569791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
    Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
    Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
    Li HC; Chen YF; Feng W; Cai H; Mei Y; Jiang YM; Chen T; Xu K; Feng DX
    Gene; 2017 Mar; 603():1-8. PubMed ID: 27916718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OIP5 Expression Sensitize Glioblastoma Cells to Lomustine Treatment.
    Rodrigues-Junior DM; Biassi TP; Carlin V; Buri MV; Torrecilhas AC; Bortoluci KR; Vettore AL
    J Mol Neurosci; 2018 Nov; 66(3):383-389. PubMed ID: 30284228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
    Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
    Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer.
    Ren X; Chen C; Luo Y; Liu M; Li Y; Zheng S; Ye H; Fu Z; Li M; Li Z; Chen R
    Mol Cancer; 2020 Feb; 19(1):35. PubMed ID: 32085715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
    Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
    Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition.
    Blum R; Nakdimon I; Goldberg L; Elkon R; Shamir R; Rechavi G; Kloog Y
    Int J Cancer; 2006 Aug; 119(3):527-38. PubMed ID: 16496386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.
    Yin J; Fu W; Dai L; Jiang Z; Liao H; Chen W; Pan L; Zhao J
    Sci Rep; 2017 Jun; 7(1):4430. PubMed ID: 28667340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Riverso M; Montagnani V; Stecca B
    Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.